"... In this placebo-controlled trial, postexposure prophylaxis with nirmatrelvir-ritonavir for 5 or 10 days did not significantly reduce the risk of symptomatic SARS-CoV-2 infection."
[That sort of has been the suspicion since the very beginning.]
pubmed.ncbi.nlm.nih.gov/390... --
New England Journal of Medicine. 2024 Jul 18;391(3):224-234 - July 17, 2024 [that is the most snooty medical journal in the US -- published by the Boston Brahmins & all that]
GoodRx in the US puts the price at $1,416 & higher for a course of treatment. "Free" ends on 12-31-24. In September 2022, both my wife & I got COVID-19; she took Paxlovid; I did not; I am severely immune deficient; we both fared the same. "Your mileage may differ." Each must make his or her own decision.